New mechanism of elevated CA125 in heart failure: The mechanical stress and inflammatory stimuli initiate CA125 synthesis

Medical Hypotheses

Volumn 79, Issue 3, 2012, Pages 381-383

  Huang, Feifei ^a,b   Chen, Jie ^a   Liu, Yimin ^a   Zhang, Kun ^a,b   Wang, Jingfeng ^a,b   Huang, Hui ^a,b  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; ESCHERICHIA COLI; HEART FAILURE; HUMAN; IN VITRO STUDY; INFLAMMATION; MECHANICAL STRESS; MESOTHELIUM CELL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RISK ASSESSMENT;

CA-125 ANTIGEN; HEART FAILURE; HUMANS; MODELS, THEORETICAL; STRESS, PHYSIOLOGICAL;

EID: 84864611174     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.05.042     Document Type: Article

References (21)

1. Spinarova L. Neurohumoral changes in chronic heart failure. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007, 151(2):201-207.
2. Nägele H., Bahlo M., Klapdor R., Schaeperkoetter D., Rödiger W. CA 125 and its relation to cardiac function. Am Heart J 1999, 137(6):1044-1049.
3. Kouris N., Zacharos I., Kontogianni D., Goranitou G., Sifaki M., Grassos H. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters. Eur J Heart Fail 2005, 7(2):199-203.
4. Yin B.W.T. Molecular cloning of the CA125 ovarian cancer antigen. Identification as a new mucin, muc16. J Biol Chem 2001, 276(29):27371-27375.
5. Gipson I.K. The ocular surface: the challenge to enable and protect vision: the friedenwald lecture. Investigative ophthalmology &. Vis Sci 2007, 48(10):4391-4398.
6. Bischof P. What do we know about the origin of CA 125. Eur J Obstet, Gynecol, Reprod Biol 1993, 49(1-2):93-98.
7. Gaetje R., Winnekendonk D.W., Ahr A., Kaufmann M. Ovarian cancer antigen CA 125 influences adhesion of human and mammalian cell lines in vitro. Clin Exp Obstet Gynecol 2002, 29(1):34-36.
8. Perez B.H., Gipson I.K. Focus on molecules: human mucin MUC16. Exp Eye Res 2008, 87(5):400-401.
9. Yilmaz M.B., Nikolaou M., Cohen Solal A. Tumour biomarkers in heart failure: is there a role for CA-125?. Eur J Heart Fail 2011, 13(6):579-583.
10. Leard L.E., Broaddus V.C. Mesothelial cell proliferation and apoptosis. Respirology 2004, 9(3):292-299.
11. Saygili U., Guclu S., Uslu T., Erten O., Dogan E. The effects of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovaria carcinoma. Int J Gynecol Cancer 2002, 12(5):438-442.
12. Molina R., Filella X., Bruix J., Mengual P., Bosch J., Calvet X., Jo J. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. Clin Chem 1991, 37(8):1379-1383.
13. Algan Ocal P., Akşahin A., Cetin T., Yildirim I.S. Cancer antigen 125 levels in patients with ascites. Turk J Gastroenterol 2003, 14(4):257-261.
14. Kosar F., Aksoy Y., Ozguntekin G., Ozerol I., Varol E. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 2006, 8(3):270-274.
15. Zeillemaker A.M., Verbrugh H.A., Hoynck van Papendrecht A.A., Leguit P. CA 125 secretion by peritoneal mesothelial cells. J Clin Pathol 1994, 47(3):263-265.
16. Colombo P.C., Ganda A., Lin J., Onat D., Harxhi A., Iyasere J.E. Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome. Heart Fail Rev 2012, 17(2):177-190.
17. Mutsaers S.E. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002, 7(3):171-191.
18. Vizzardi E., D'Aloia A., Pezzali N., Bugatti S., Curnis A., Dei Cas L. Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients. J Card Fail 2012, 18(1):68-73.
19. Duman D., Palit F., Simsek E., Bilgehan K. Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume. Eur J Heart Fail 2008, 10(6):556-559.
20. Nunez J., Sanchis J., Bodi V., Fonarow G.C., Nunez E., Bertomeu-Gonzalez V. Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure. Eur Heart J 2010, 31(14):1752-1763.
21. Sikaris K.A. CA125-A test with a change of heart. Heart, Lung and Circulation 2011, 20(10):634-640.